The predictive value of hospital admission serum alanine transaminase activity in patients treated for paracetamol overdose
|
|
- Robert Robinson
- 6 years ago
- Views:
Transcription
1 Q J Med 2013; 106: doi: /qjmed/hct062 Advance Access Publication 2 April 2013 The predictive value of hospital admission serum alanine transaminase activity in patients treated for paracetamol overdose K. AL-HOURANI, R. MANSI, J. PETTIE, M. DOW, D.N. BATEMAN and J.W. DEAR From the National Poisons Information Service Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK Address correspondence to Dr J.W. Dear, Consultant Clinical Pharmacologist, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK. james.dear@luht.scot.nhs.uk Received 4 January 2013 and in revised form 13 February 2013 Summary Background: Paracetamol is a major cause of poisoning. Treatment decisions are predominately based on the dose ingested and a timed blood paracetamol concentration because most patients present to hospital soon after overdose, before hepatotoxicity can be confirmed/excluded using serum alanine transaminase (ALT). Nonetheless, ALT is measured at hospital presentation; we investigated its value in predicting hepatotoxicity. Methods: From March 2011 to May 2012, patients admitted to the Royal Infirmary of Edinburgh for paracetamol overdose treatment were identified. We determined the value of admission ALT (below or above our upper limit of normal 50 IU/l) at predicting three endpoints: 1 doubling of ALT; 2 peak ALT >1000 IU/l; 3 peak international normalized ratio (INR) >2. Results: From 500 patients, 410 met the entry criteria; 264 presented within 8 h of overdose, 54 between 8 and 24 h, 53 after 24 h and 39 were staggered ingestions. Admission ALT was increased in 71. For endpoint 1 (ALT doubling), the positive predictive value (PPV) of admission ALT was 19% [95% confidence interval (CI) 12 30] with a negative predictive value (NPV) of 98% (95% CI 96 99); endpoint 2 (ALT >1000 IU/l: PPV 23% (95% CI 14 34) and NPV 100% (95% CI ) and for endpoint 3 (INR >2): PPV 14% (95% CI 7 25) and NPV of 100% (95% CI ). The NPV remained high when only late presenters were included. Conclusion: Admission ALT within the normal range has a high NPV and could be used, alone or in combination with newer biomarkers, to identify lower risk patients at hospital presentation. Introduction Paracetamol (acetaminophen) is the most commonly overdosed drug in UK and a leading cause of acute liver failure in the Western world. 1 It accounts for >40% of poisoning episodes that are admitted to hospital: emergency hospital admissions in the financial year in England alone. 2 In UK, guidance on the management of paracetamol overdose is available through resources such as TOXBASE ( and the British National Formulary, with need for treatment being largely determined by the dose ingested and timed plasma paracetamol concentration. 3 With the mechanism of paracetamol hepatotoxicity extensively investigated, the current mainstay of treatment available for paracetamol poisoning is replenishment of cellular glutathione through the administration of acetylcysteine (AC). Although early treatment with AC effectively prevents hepatotoxicity, its efficacy declines if treatment is delayed >8 h after overdose; patients presenting late to! The Author Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please journals.permissions@oup.com
2 542 K. Al-Hourani et al. hospital are at an increased risk of significant liver injury. 4 It is essential to triage patients presenting with paracetamol overdose into those in whom hepatic damage is likely and those in whom it is unlikely. Such hospital front door stratification would allow new therapeutic approaches to be targeted at lower or higher risk groups and increase the likelihood of clinical trials being successful. At present, a timed blood paracetamol concentration is measured to stratify patients into two groups; those needing AC treatment and those who do not require antidote. However, a significant proportion of patients are misclassified as needing treatment as they would not get liver injury if untreated. 5 Furthermore, within the treated group further stratification could lead to the AC dose being individualized depending on risk of liver injury. Although it is rare for a patient to develop toxicity if their blood paracetamol concentration is below the at-risk line on the treatment nomogram, such cases do occur and have resulted in potentially avoidable deaths and, therefore, great concern for both clinicians and medicine regulators. 6 Alanine transaminase (ALT) has the potential to aid treatment decisions at the hospital front door. In this study, we tested the performance of serum ALT activity at hospital admission as a predictor of subsequent injury in a large cohort of patients who received AC treatment. Methods The Edinburgh Clinical Toxicology Unit has a database of all patients admitted to the toxicology ward at the Royal Infirmary of Edinburgh (RIE), UK, with excess paracetamol ingestion that required treatment with intravenous AC. This does not include patients directly admitted to the Scottish Liver Transplantation Unit, also based at RIE. This database was the source of patient identification. Exclusion criteria were as follows: patients who did not complete AC treatment; patients whose bloods were not repeated at end of AC, haemolysed or had no INR taken. In this study, we have included patients from March 2011 to May The performance of hospital admission serum ALT activity (greater than the upper limit of our hospital s normal range, 50 IU/l) was tested as a predictor of three endpoints. Endpoint 1 was doubling of ALT from admission to the end of first h course of AC therapy. Endpoint 2 was a peak hospital stay ALT >1000 IU/l. Endpoint 3 was a peak international normalized ratio (INR) value >2. Patient blood results were extracted from RIE blood results system, which stores all patient data from NHS Lothian on an electronic database. Care was taken to maintain patients confidentiality through removal of all patient-identifiable data and secure storage within the National Health Service. Positive and negative predictive values (PPV and NPV), specificities and sensitivities with 95% confidence intervals (CIs) were calculated for hospital admission ALT. Furthermore, results were divided according to time from ingestion to first blood sample up to 8 h, 8 24 h, >24 h and staggered overdose (ingested over 2 h or more). The statistical package used to calculate these values was an online resource provided by the Canadian Institute for Health Research ( Results A total of 500 patients were admitted for AC treatment in the period March 2011 May In total, 90 were excluded from the study because they fulfilled one or more of our exclusion criteria (73 patients had no end of AC treatment blood results, eight patients had haemolysed blood results and remaining nine patients had no INR measurement). Table 1 provides a summary of the patient demographics. About 264 presented to hospital within 8 h of the overdose, 54 presented within 8 24 h, 53 presented 24 h after overdose and 39 were staggered overdoses (ingested over 2 h or more) (Table 2). On admission to hospital, serum ALT activity was increased above the normal limit (>50 IU/l) in 71 patients. The breakdown of this by time interval from ingestion is presented in Table 2. Table 2 presents the PPV, NPV, sensitivity and specificity with 95% CIs for admission ALT. For endpoint 1 (doubling of ALT from admission), there was an overall PPV of 19.1% with the highest PPV (50%) being in those presenting 24 h after the overdose. In contrast, the NPV of admission ALT for endpoint 1 was 98%. Table 1 Demographics of our cohort Total Number 410 Sex (M:F) 151:259 Median age (range) 37 (13 90) Number admission ALT < ULN 339 Number admission ALT > ULN 71 Number admission ALT > Number peak ALT > Number normal INR 402 Number peak INR >2 8 ULN, upper limit of normal.
3 Predictive value of hospital admission serum alanine transaminase activity 543 Table 2 Total number of patients at each interval following overdose and proportion who reached the endpoint Time interval from overdose Total number of patients Number of admission ALT > ULN Endpoint Number reaching endpoint n (%) NPV (95% CI) PPV (95% CI) Sensitivity (95% CI) Specificity (95% CI) Overall Doubling of ALT 20 (4.9) 0.98 ( ) 0.19 ( ) 0.65 ( ) 0.86 ( ) 2. Peak ALT 1000 IU/l 16 (3.9) 1.00 ( ) 0.23 ( ) 1.0 ( ) 0.86 ( ) 3. INR >2 8 (1.9) 1.0 ( ) 0.14 ( ) 1.0 ( ) 0.87 ( ) 0 8 h Doubling of ALT 7 (2.7) 0.98 ( ) 0.08 ( ) 0.43 ( ) 0.86 ( ) 2. Peak ALT 1000 IU/l 3 (1.1) 1.0 ( ) 0.08 ( ) 1.0 ( ) 0.87 ( ) 3. INR >2 3 (1.1) 1.0 ( ) 0.09 ( ) 1.0 ( ) 0.88 ( ) 8 24 h Doubling of ALT 3 (5.6) 0.96 ( ) 0.17 ( ) 0.33 ( ) 0.90 ( ) 2. Peak ALT 1000 IU/l ( ) (0 1.0) 0.84 ( ) 3. INR > ( ) ( ) >24 h Doubling of ALT 9 (17.0) 0.97 ( ) 0.50 ( ) 0.89 ( ) 0.82 ( ) 2. Peak ALT 1000 IU/l 10 (18.9) 1.0 ( ) 0.63 ( ) 1.0 ( ) 0.86 ( ) 3. INR >2 4 (7.5) 1.0 ( ) 0.33 ( ) 1.0 ( ) 0.83 ( ) Staggered Doubling of ALT 1 (2.6) 1.0 ( ) 0.13 ( ) 1 ( ) 0.82 ( ) 2. Peak ALT 1000 IU/l 3 (7.7) 1.0 ( ) 0.38 ( ) 1.0 ( ) 0.85 ( ) 3. INR >2 1 (2.6) 1.0 ( ) 0.13 ( ) 1 (0.21 1) 0.82 ( )
4 544 K. Al-Hourani et al. Endpoint 2 tested the performance of admission ALT as a predictor of ALT peaking above 1000 IU/l. The overall PPV was 22.5%, with the PPV of those presenting 24 h after presentation being 62.5%. The NPV was 100% across all time intervals. Endpoint 3 tested admission ALT against peak INR >2. PPV remained low at 13.6%; however, NPV was 100%. Once more, the PPV was uniformly low across all durations, demonstrating a peak of 33.3% for those presenting >24 h after overdose. Increasing time between overdose and starting treatment with AC increases the risk of hepatotoxicity. For all three endpoints, the NPV of hospital admission ALT was high in patients presenting late to hospital (Table 2). Out of the 53 patients who presented >24 h after a single ingestion, 10 had a peak hospital stay ALT >1000 IU/l. In this high-risk group, a normal ALT at presentation still had a 100% NPV. Staggered paracetamol overdoses are challenging to manage clinically because the risk nomogram cannot be used. Although the numbers of these patients were small (n = 39), a normal ALT at presentation still had a 100% NPV. Discussion Paracetamol is the commonest drug taken in overdose in UK 7,8 with an estimated hospital admission rate of 48% of all overdoses, unfortunately leading to deaths per year. 9 In Scotland, patients per year develop significant hepatic dysfunction following paracetamol overdose (ALT > 1000 IU/l or INR > 2) and around 20 patients die per year as a result of overdose. 10 Although the management of early paracetamol overdose is relatively straightforward, cases presenting late, following a staggered overdose or those with additional risk factors, present a more complex clinical picture. Currently, UK management of paracetamol overdose is derived from guidelines formulated by the National Poisons Information Service. As little as g of paracetamol taken within 24 h could be enough to induce hepatocellular and renal tubular necrosis. For this reason, appropriate timely treatment is vital. 10 Recently, the UK management of paracetamol overdose has been changed following reviews by the Medicines and Healthcare products Regulatory Agency. 6 A single-line treatment nomogram is used to determine need for AC treatment based on a timed blood paracetamol concentration. This new nomogram may result in substantially more patients being admitted to hospital for AC treatment. 11 As patients who present early to hospital typically have no symptoms or signs of hepatotoxicity, there is an urgent need to develop new circulating biomarkers that inform treatment decisions at the hospital front door. Such markers have the potential to refine patient care in a number of important ways. Future clinical trials of new therapeutic strategies could be stratified using one or more biomarkers with the objective of targeting new therapies or management pathways at lower or higher risk patients. Qualification of new biomarkers may galvanize the interest of pharma in developing new treatments as patient stratification can significantly improve the cost-effectiveness, and therefore health service use of new drugs. If such trials were successful, more individualized treatment would be possible at the hospital front door, as is already the case with the management of acute coronary syndromes (being routinely stratified by sensitive cardiac biomarkers such as troponin). Currently, patients who have taken a single paracetamol overdose, who present late to hospital, can only have liver injury confidently excluded if their standard liver function tests are normal around h after overdose. Biomarkers may allow earlier exclusion of injury which would have an impact on hospital bed occupancy and avoid adverse AC reactions by reducing unnecessary treatment. Patients with a timed blood paracetamol concentration below the at-risk line on the treatment nomogram are usually not treated. Sensitive biomarkers of hepatotoxicity may increase physician confidence in discharging the patient from hospital and could reduce the number of patients being incorrectly classified as not needing treatment. Serum ALT activity is the most frequently used laboratory indicator of hepatotoxicity. 12,13 It is commonly measured on first presentation to hospital, but at present, it is not used to guide treatment decisions because most patients present to hospital soon after drug ingestion (70% within 4 h of overdose). 2 Unfortunately, this remains a timeframe when ALT cannot diagnose or exclude liver injury. Our study has demonstrated that a normal admission ALT has a high NPV for subsequent liver injury if AC course is completed. This is consistent with a previous study of 94 patients, all of whom had a peak transaminase activity >1000 IU/l. 14 In this Canadian cohort of patients with significant hepatotoxicity, transaminase activity was already increased at hospital admission. As already stated, ALT has important limitations as a biomarker, so our group has recently investigated a panel of new circulating biomarkers that have enhanced liver selectivity (microrna 122) or provide mechanistic information (HMGB1 and keratin-18) in plasma from patients following paracetamol overdose. 15 In patients who
5 Predictive value of hospital admission serum alanine transaminase activity 545 developed hepatotoxicity, these markers were substantially increased on first presentation to hospital at a time when ALT was still in the normal range. This demonstrated that patients who develop paracetamol-induced hepatotoxicity have evidence of cellular damage soon after overdose and is proof of concept that front door biomarker development is possible for this common poison. In the present study, the NPV of ALT was high even in patients presenting >8 h after overdose, although these patient numbers were relatively small. Therefore, this straightforward, routinely available test could be used to identify lower risk patients. There are two scenarios where this could be useful. Currently, all patients are treated with the same dose of AC. It is probable that this leads to some patients being over-treated 16 resulting in avoidable adverse drug reactions to AC and unnecessary hospital bed occupancy. Hospital admission ALT within the normal range identifies a low-risk group and could be used as inclusion criteria for clinical trials of new targeted therapeutic strategies. New circulating biomarkers are in clinical development that appears more sensitive than ALT. 17,18 These may make it possible to better identify lower risk patients and allow earlier rule in/rule out of liver cell death following paracetamol overdose. Our findings suggest that admission ALT can be used to inform the treating clinician about patient prognosis; if the ALT activity is within the normal range and the patient completes treatment, then liver injury is unlikely, even in patients who present late to hospital. In contrast, an increased ALT activity at presentation to hospital had a low PPV. This can probably be explained through the knowledge that serum ALT activity is increased in co-morbidities such as alcohol excess, biliary disease, diabetes, obesity, heart failure and myopathy. Therefore, our findings indicate that an increased ALT alone cannot be used to identify higher risk patients at first presentation to hospital, whereas a normal ALT may be useful in identifying patients at lower risk. Conclusion Our study tested the predictive value of admission serum ALT activity in paracetamol overdose. It demonstrated that on first presentation to hospital, normal serum ALT is a predictor of very low risk of subsequent liver injury on completion of AC. If confirmed in larger clinical studies, this simple test could be used, alone or in combination with new biomarkers, to identify low-risk patients for clinical trials of novel therapeutic strategies. Acknowledgements J.W.D. acknowledges the contribution of the British Heart Foundation Centre of Research Excellence Award. Funding J.W.D. acknowledges the funding of NHS Research Scotland through NHS Lothian. Conflict of interest: None declared. References 1. Marudanayagam R, Shanmugam V, Gunson B, Mirza DF, Mayer D, Buckels J, et al. Aetiology and outcome of acute liver failure. HPB 2009; 11: Prescott K, Stratton R, Freyer A, Hall I, Le Jeune I. Detailed analyses of self-poisoning episodes presenting to a large regional teaching hospital in the UK. Br J Clin Pharamacol 2009; 68: Pettie JM, Dow DA, Sandilands EA, Thanacoody HK, Bateman DN. An integrated care pathway improves the management of paracetamol poisoning. Emer Med J 2012; 29: Prescott LF. Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Arch Intern Med 1981; 141: Prescott LF. Paracetamol (Acetaminophen). A Critical Bibiliographic Review. London, Taylor & Francis, Medicine and Healthcare products Regulatory Agency. Paracetamol overdose: simplification of the use of intravenous acetylcysteine. tion/safetywarningsalertsandrecalls/safetywarningsand messagesformedicines/con (24 March 2013, date last accessed). 7. Thomas SHL, Bevan L, Bhattacharyya S, Bramble MG, Chew K, Connolly J, et al. Presentation of poisoned patients to accident and emergency departments in the North of England. Hum Exp Toxicol 1996; 15: Bialas MC, Reid PG, Beck P, Lazarus JH, Smith PM, Scorer RC, et al. Changing patterns of self-poisoning in a UK health district. Q J Med 1996; 89: Fagan E, Wanna G. Reducing paracetamol overdoses. BMJ 1996; 313: Bateman DN. Poisoning: Focus on paracetamol. J R Coll Physicians Edin 2007; 37: McQuade DJ, Dargan PI, Keep J, Wood DM. Paracetamol toxicity: what would be the implications of a change in UK treatment guidelines? Eur J Clin Pharmacol 2012; 68: Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol 1998; 27: Amacher DE. A toxicologist s guide to biomarkers of hepatic response. Hum Exp Toxicol 2002; 21: Green TJ, Sivilotti MLA, Langmann C, Yarema M, Juurlink D, Burns MJ, et al. When do the aminotransferases rise
6 546 K. Al-Hourani et al. after acute acetaminophen overdose? ClinToxicol 2010; 48: Antoine DJ, Dear JW, Starkey-Lewis P, Platt V, Coyle J, Masson M, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology, doi: /hep [Epub 6 February 2013]. 16. Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol 2012; 50: Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, et al. Circulating microrna as potential markers of human drug-induced liver injury. Hepatology 2011; 54: Antoine DJ, Jenkins RE, Dear JW, Williams DP, McGill MR, Sharpe MR, et al. Molecular forms of HMGB1 and Keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012; 56:
The predictive value of serum alanine transaminase activity on first presentation to hospital in patients with paracetamol poisoning
The predictive value of serum alanine transaminase activity on first presentation to hospital in patients with paracetamol poisoning Khalid Al-Hourani, Rachel Mansi, Janice Pettie, Margaret Dow, Nick Bateman
More informationNewcastle University eprints
Newcastle University eprints Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, Bateman DN, Goldring CE, Park BK. Mechanistic biomarkers provide early
More informationChanges in paracetamol, antidepressants and opioid poisoning in Scotland during the 1990s
Q J Med 2003; 96:125 132 doi:10.1093/qjmed/hcg015 Changes in paracetamol, antidepressants and opioid poisoning in Scotland during the 1990s D.N. BATEMAN, M. BAIN 1,D.GORMAN 2 and D. MURPHY 1 From the Scottish
More informationDoes the patient history predict hepatotoxicity after acute paracetamol overdose?
Q J Med 28; 11:121 125 doi:1.193/qjmed/hcm139 Advance Access published on 7 January 28 Does the patient history predict hepatotoxicity after acute paracetamol overdose? W.S. WARING, O.D.G. ROBINSON, A.F.L.
More informationParacetamol Overdose Clinical Audit
The College of Emergency Medicine Clinical Audits Paracetamol Overdose Clinical Audit 2013-14 EXCELLENCE IN EMERGENCY MEDICINE Contents Executive Summary 3 Introduction 4 CEM Standards 4 Audit background
More informationMeasuring plasma paracetamol concentrations in all patients with drug overdose or altered consciousness: Does it change outcome?
178 Medical Toxicology Unit, Guy s and St Thomas s Hospitals, Avonley Road, London SE14 5ER, UK Correspondence to: Dr Dargan (paul.dargan@gstt.sthames. nhs.uk) Accepted for publication 12 June 2000 Measuring
More informationRisk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies James W Dear*, Joanna I Clarke*, Ben Francis, Lowri Allen, Jonathan Wraight, Jasmine
More informationRisk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies James W Dear*, Joanna I Clarke*, Ben Francis, Lowri Allen, Jonathan Wraight, Jasmine
More informationPharmacokinetic modelling of a high dose acetylcysteine regimen based on the SNAP trial
Pharmacokinetic modelling of a high dose acetylcysteine regimen based on the SNAP trial Ruben Thanacoody National Poisons Information Service (Newcastle) Newcastle upon Tyne Hospitals NHS Trust Medical
More informationparacetamol overdose: evidence for early hepatocellular damage
Gut, 1985, 26, 26-31 Plasma glutathione S-transferase measurements after paracetamol overdose: evidence for early hepatocellular damage G J BECKETT, B J CHAPMAN, E H DYSON, AND J D HAYES From the University
More informationHUMAN TOXICOLOGY Outcomes from massive paracetamol overdose: a retrospective observational study
British Journal of Clinical Pharmacology Br J Clin Pharmacol (2017) 83 1263 1272 1263 HUMAN TOXICOLOGY Outcomes from massive paracetamol overdose: a retrospective observational study Correspondence Dr
More informationSaião A, Chan B, Isbister GK Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, NSW Emergency Department, Prince of Wales
Saião A, Chan B, Isbister GK Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, NSW Emergency Department, Prince of Wales Hospital, Sydney, NSW, Australia Paracetamol Poisoning
More informationDrug Induced Liver Injury (DILI)
Drug Induced Liver Injury (DILI) Aisling Considine- Consultant Hepatology Pharmacist. King s College Hospital NHS Foundation Trust aislingconsidine@nhs.net Drug Induced Liver Injury /Disease Acute Liver
More informationStaggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamolinduced hepatotoxicity
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2011.04067.x Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamolinduced
More informationSerum microrna biomarkers for human DILI
CLEARANCE DRUG bioactivation covalent binding Detoxication GLUCURONIDE SULPHATE DRUG + METABOLITE chemical stress mitochondrial dysfunction apoptosis necrosis hepatocyte hypertrophy hepatocyte hyperplasia
More informationChapter 143 Acetaminophen
Chapter 143 Acetaminophen Episode overview 1) Describe the metabolism of Acetaminophen 2) Describe the 4 stages of Acetaminophen toxicity 3) List 4 mechanism of action of N-acetylcysteine 4) When do you
More informationParacetamol-Protein Adducts following Acute Paracetamol Overdose
Paracetamol-Protein Adducts following Acute Paracetamol Overdose Angela Chiew (1), Laura P James (2), Lynda G Letzig (2), Geoffrey K Isbister (3), Nicholas A Buckley (4) (1)Clinical Toxicology Unit/ Emergency
More informationUNUSUAL ACETAMINOPHEN TOXICITY SCENARIOS. Gosselin
UNUSUAL ACETAMINOPHEN TOXICITY SCENARIOS Objec-ves Management of acetaminophen inges-ons when the Rumack- Ma
More informationThe Association of British Clinical Diabetologists (ABCD) Clinical Audit Programme
The Association of British Clinical Diabetologists (ABCD) Clinical Audit Programme 2009-10 An audit of Inpatient Diabetes Care across NHS Lothian; The effectiveness of the use of information technology,
More informationD DAVID PUBLISHING. 1. Introduction. 2. Methods. Samira Green 1, Vanessa Jessop 2, Jason Pott 2 and Tim Harris 2
Journal of Health Science 2 (2014) 523-528 doi: 10.17265/2328-7136/2014.11.001 D DAVID PUBLISHING Management, Triage and Outcomes of 378 Patients Presenting to the Emergency Department with Chest Pain
More informationDevelopment of a patient information leaflet for use following assessment of patients with reported or suspected paracetamol overdose in the UK
ORIGINAL ARTICLE Development of a patient information leaflet for use following assessment of patients with reported or suspected paracetamol overdose in the UK Thomas Potter 1, Wui Ling Chan 2, John R.
More informationDetailed analyses of self-poisoning episodes presenting to a large regional teaching hospital in the UK
British Journal of Clinical Pharmacology DOI:1.1111/j.1365-2125.9.3458.x Detailed analyses of self-poisoning episodes presenting to a large regional teaching hospital in the UK Katherine Prescott, 1 Richard
More informationAmmonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality
More informationAntiemetic Use in Acetaminophen Poisoning: How Does the Route of N-acetylcysteine Administration Affect Utilization?
Toxicology Investigations Antiemetic Use in Acetaminophen Poisoning: How Does the Route of N-acetylcysteine Administration Affect Utilization? Melissa A. Miller, PharmD a, Marisela Navarro, PharmD a, Steven
More informationa Clinical Pharmacology Service and b Liver Unit, Hospital Universitario, School of
Original article 59 The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment M. Isabel Lucena a, Enrique
More informationQuantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate
Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate BMJ Jenny H Humphreys, Alexander Warner, Ruth Costello, Mark Lunt, Suzanne M M Verstappen,
More informationInstitute of Cellular Medicine, Newcastle University (United Kingdom)
Curriculum vitae PERSONAL INFORMATION Ruben Thanacoody WORK EXPERIENCE 2009 Present Consultant in Acute Medicine with an interest in Clinical Toxicology, Royal Victoria Infirmary, Newcastle-upon-Tyne and
More informationCLINICAL REVIEW. Management of paracetamol poisoning. Robin E Ferner, 1 2 James W Dear, 3 4 D Nicholas Bateman 3
For the full versions of these articles see bmj.com Management of paracetamol poisoning Robin E Ferner, 1 2 James W Dear, 3 4 D Nicholas Bateman 3 1 West Midlands Centre for Adverse Drug Reactions, City
More informationThe OPRAA Cohort. Emma Reynish
The OPRAA Cohort Emma Reynish Chair of Dementia Research, Faculty of Social Science, University of Stirling. Consultant Geriatrician, Royal Infirmary Edinburgh, NHS Lothian Standardised Assessment of older
More informationGuidelines for the Management of Acetaminophen Overdose
Guidelines for the Management of Acetaminophen Overdose PROFESSIONAL PRODUCT INFORMATION Guidelines for the Management of Acetaminophen Overdose This brochure outlines basic steps in the management of
More informationEvidence for the changing regimens of acetylcysteine
British Journal of Clinical Pharmacology DOI:10.1111/bcp.12789 Evidence for the changing regimens of acetylcysteine Angela L. Chiew, 1,2 Geoffrey K. Isbister, 3,4 Stephen B. Duffull 5 & Nicholas A. Buckley
More informationAn agenda for UK clinical pharmacology UK medicines policy: the role of clinical pharmacologists
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2012.04244.x Commentary An agenda for UK clinical pharmacology UK medicines policy: the role of clinical pharmacologists David J. Webb Queen
More informationOutcome following surgery for colorectal cancer
Outcome following surgery for colorectal cancer Colin S McArdle* and David J Hole *University Department of Surgery, Glasgow Royal Infirmary, Glasgow and Department of Public Health, University of Glasgow,
More informationabcdefghijklmnopqrstu
Health Workforce Directorate Employment and Retention Division Dear Colleague Best Practice Guidance Hepatitis B infected healthcare workers and antiviral therapy abcdefghijklmnopqrstu CEL 38 (2009) Date
More informationThe AHEAD Study: Managing anticoagulatedpatients who suffer head injury
AHEAD Study The AHEAD Study: Managing anticoagulatedpatients who suffer head injury Suzanne Mason 1,2, Maxine Kuczawski 1, Matthew Stevenson 1, Dawn Teare 1, Michael Holmes 1, ShammiRamlakhan 1, Steve
More informationUnderstanding Alcohol Misuse in Scotland HARMFUL DRINKING. Three: Alcohol and Self-harm
Scottish Emergency Department Alcohol AuditSEDAA Understanding Alcohol Misuse in Scotland HARMFUL DRINKING Three: Alcohol and Self-harm Scottish Emergency Department Alcohol AuditSEDAA Understanding Alcohol
More informationP aracetamol (acetaminophen) poisoning is an increasing
686 LIVER ge and paracetamol self-poisoning L E Schmidt... Gut 2;4:686 69. doi: 1.1136/gut.24.4619... Correspondence to: Dr L E Schmidt, Department of Hepatology. 2.12.1, Rigshospitalet, Blegdamsvej 9,
More informationEdinburgh Research Explorer
Edinburgh Research Explorer UK legislation on analgesic packs Citation for published version: Hawton, K, Simkin, S, Deeks, J, Cooper, J, Johnston, A, Waters, K, Arundel, M, Bernal, W, Gunson, B, Hudson,
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association Early presentation following overdose of modified-release paracetamol (Panadol Osteo) with biphasic and prolonged paracetamol
More informationAssociation of aspartate aminotransferase in statin-induced rhabdomyolysis
Association of aspartate aminotransferase in statin-induced rhabdomyolysis Xu Cong Ruan BSc (Pharm)(Hons), MD; Lian Leng Low MBBS, MMed (Fam Med); 2 Yu Heng Kwan BSc (Pharm)(Hons) 3 MD Candidate; Duke-NUS
More informationBassett Healthcare Clinical Laboratory
Therapeutic Drug Level Collection Guidelines Anti-epileptic drugs (carbamazepine, phenobarbital, phenytoin, primidone, valproic acid) Consider collecting after steady state conditions are reached, i.e.
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationSuicidal Behaviour among Young Adults (15-34 years)
Scottish Needs Assessment Programme Suicidal Behaviour among Young Adults (15-34 years) Summary Progress Report SCOTTISH FORUM FOR PUBLIC HEALTH MEDICINE 69 Oakfield Avenue Glasgow G12 8QQ Tel - 0141 330
More informationDeliberate self-harm in Oxford, : a time of change in patient characteristics
Psychological Medicine, 2003, 33, 987 995. f 2003 Cambridge University Press DOI: 10.1017/S0033291703007943 Printed in the United Kingdom Deliberate self-harm in Oxford, 1990 2000: a time of change in
More informationUnnecessary hospitalisation and investigation of low risk patients presenting to hospital with chest pain
Unnecessary hospitalisation and investigation of low risk patients presenting to hospital with chest pain Michael Perera Advanced Trainee in General and Acute Medicine Leena Aggarwal Director, Medical
More informationC ardiac arrest remains a leading cause of cardiovascular
619 PREHOSPITAL CARE Surviving out of hospital cardiac arrest at home: a postcode lottery? R M Lyon, S M Cobbe, J M Bradley, N R Grubb... See end of article for authors affiliations... Correspondence to:
More informationAnnex A: Estimating the number of people in problem debt while being treated for a mental health crisis
Annex A: Estimating the number of people in problem debt while being treated for a mental health crisis A.1 Estimating the number of referrals to NHS crisis response teams in England per year Unfortunately
More informationRelationship between body mass index and length of hospital stay for gallbladder disease
Journal of Public Health Vol. 30, No. 2, pp. 161 166 doi:10.1093/pubmed/fdn011 Advance Access Publication 27 February 2008 Relationship between body mass index and length of hospital stay for gallbladder
More informationParacetamol Poisoning in Children
Introduction Paracetamol Poisoning in Children Rojo Joy Junior Resident-Pediatrics, JIPMER, Puducherry Rojo Villa, 33/5600, Chevayur P.O, Calicut, Kerala Paracetamol is one of the most commonly used drug
More informationDolore Toracico e Livelli di Troponina non Misurabili
Dolore Toracico e Livelli di Troponina non Misurabili Andrea Fabbri Dipartimento di Emergenza Presidio Ospedaliero Morgagni Pierantoni Azienda USL Romagna Forlì andrea.fabbri@auslromagna.it Rapid Exclusion
More informationChronic acetaminophen toxicity: lack of consensus
Chronic acetaminophen toxicity: lack of consensus Lia Mano 1, AP Campos 2, F Candeias 1, MJ Brito 1 1 - Pediatric Infectious Diseases Unit 2 - Pediatric Gastroenterology Unit Hospital Dona Estefânia CHLC
More informationmirnas as Biomarkers for Drug-Induced Liver Injury and as Predictors in Clinical Trials
mirnas as Biomarkers for Drug-Induced Liver Injury and as Predictors in Clinical Trials Herbert L. Bonkovsky, M.D. Professor of Medicine Wake Forest University School of Medicine Chief of Hepatology, NC
More informationDILI: Clinical Pharmacology Considerations for Risk Assessment
DILI: Clinical Pharmacology Considerations for Risk Assessment Raj Madabushi, PhD Office of Clinical Pharmacology Drug-Induced Liver Injury (DILI) Conference XVII June 06, 2017 Disclaimer: The views expressed
More informationTransplant Psychiatry. Stephen Potts & Roger Smyth Department of Psychological Medicine Royal Infirmary of Edinburgh
Transplant Psychiatry Stephen Potts & Roger Smyth Department of Psychological Medicine Royal Infirmary of Edinburgh Liver / Recipient Functions of the liver largest solid organ with ~500 functions
More informationAcetaminophen overdose is the most common cause of
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:918 925 ORIGINAL ARTICLES LIVER, PANCREAS AND BILIARY TRACT Impact of Liver Disease, Alcohol Abuse, and Unintentional Ingestions on the Outcomes of Acetaminophen
More informationScottish Medicines Consortium
Scottish Medicines Consortium anidulafungin 100mg powder and solvent for concentrate for solution for infusion (Ecalta ) No. (465/08) Pfizer Ltd 09 May 2008 The Scottish Medicines Consortium (SMC) has
More informationOf those with dementia have a formal diagnosis or are in contact with specialist services. Dementia prevalence for those aged 80+
Dementia Ref HSCW 18 Why is it important? Dementia presents a significant and urgent challenge to health and social care in County Durham, in terms of both numbers of people affected and the costs associated
More informationPreoperative tests (update)
National Institute for Health and Care Excellence. Preoperative tests (update) Routine preoperative tests for elective surgery NICE guideline NG45 Appendix N: Research recommendations April 2016 Developed
More informationRisk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium
Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from
More informationNHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.
Advice Statement 010-18 July 2018 Advice Statement What is the most accurate and cost-effective direct test (ELF test, hyaluronic acid, P3NP, Fibroscan or ARFI elastography) for detecting and staging liver
More informationAutoimmune Hepatitis: Defining the need for Liver Transplantation
Autoimmune Hepatitis: Defining the need for Liver Transplantation Michael A Heneghan, MD, MMedSc, FRCPI. Institute of Liver Studies, King s College Hospital, London Outline Autoimmune Hepatitis Background
More informationSurveillance of Surgical Site Infection Annual Report For procedures carried out from: January December 2009
Surveillance of Surgical Site Infection Annual Report For procedures carried out from: January 2003 - December 2009 Scottish Surveillance of Healthcare Associated Infection Programme (SSHAIP) Contents
More informationabcdefghijklmnopqrstu
Chief Medical Officer Directorate Chief Medical Officer and Secretariat Division abcdefghijklmnopqrstu T: 0131-244 2399 F: 0131-244 2989 E: sandra.falconer@scotland.gsi.gov.uk NHS Board Medical and Nursing
More information... REPORTS... The Use and Effect of Analgesics in Patients Who Regularly Drink Alcohol. Richard C. Dart, MD, PhD
... REPORTS... The Use and Effect of Analgesics in Patients Who Regularly Drink Alcohol Richard C. Dart, MD, PhD Abstract Analgesic consumption poses special risks for regular users of alcohol. Among the
More informationNational Horizon Scanning Centre. Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis. June 2008
Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis June 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not intended
More informationGuidelines on the Administration of Paracetamol in Children
DERBY HOSPITALS NHS FOUNDATION TRUST DIVISION OF INTEGRATED MEDICINE PAEDIATRICS Guidelines on the Administration of Paracetamol in Children REF NO: CH PH GE 17 Reference Number: CH PH GE 17 Version: 5
More informationInformation for general practitioners
Information for general practitioners Mycobacterium chimaera: Assessing patients who have had cardiothoracic surgery or extracorporeal membrane oxygenation (ECMO) Background It is now recognised that patients
More informationItem Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING. Meeting Date: 7 November Report Author: Report Sponsor:
Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING Meeting Date: 7 November 2013 Report Sponsor: Dr Emma Broughton Clinical Lead for Primary Care Programme Report Author:
More informationUnderstanding our advice ~ December The use of troponin testing in acute coronary syndromes
Understanding our advice ~ December 2003 The use of troponin testing in acute coronary syndromes The use of troponin testing in acute coronary syndromes Purpose of this document NHS Quality Improvement
More informationα-glutathione S-Transferase: A New Biomarker for Liver Injury?
α-glutathione S-Transferase: A New Biomarker for Liver Injury? Ian Maina, 1 Jody A. Rule, 1 Frank H. Wians, Jr., 2 Michael Poirier, 3 Lafaine Grant, 1 and William M. Lee, 1 * for the Acute Liver Failure
More informationDrug combinations and impaired renal function the triple whammy
DOI:10.1111/j.1365-2125.2004.02188.x British Journal of Clinical Pharmacology Drug combinations and impaired renal function the triple whammy Katarzyna K. Loboz & Gillian M. Shenfield 1 Department of Pharmacology,
More informationAcetaminophen Poisoning: an Evidence-Based Consensus Guideline for Out-of-Hospital Management
Clinical Toxicology ISSN: 1556-3650 (Print) 1556-9519 (Online) Journal homepage: http://www.tandfonline.com/loi/ictx20 Acetaminophen Poisoning: an Evidence-Based Consensus Guideline for Out-of-Hospital
More informationSurveillance of Surgical Site Infection Annual Report For procedures carried out from: January December 2010
Surveillance of Surgical Site Infection Annual Report For procedures carried out from: January 2003 - December 2010 Scottish Surveillance of Healthcare Associated Infection Programme (SSHAIP) Table of
More informationABSTRACT 740 ACADEMIC EMERGENCY MEDICINE AUG 1996 VOL 3/NO 8
740 ACADEMIC EMERGENCY MEDICINE AUG 1996 VOL 3/NO 8 A Pharmacokinetic Comparison of Acetaminophen Products (Tylenol d Extended Relief vs Regular Tylenol) Daniel R. Douglas, MD, James B. Sholal; MD, Martin
More informationAcetaminophen (APAP: N-acetyl-para-aminophenol)
Mathematical Modeling of Liver Injury and Dysfunction After Acetaminophen Overdose: Early Discrimination Between Survival and Death Christopher H. Remien, 1 Frederick R. Adler, 1,2 Lindsey Waddoups, 3
More informationEffects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study
Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study Keith Hawton, Ellen Townsend, Jonathan Deeks, Louis Appleby,
More informationHepatotoxicity and ALT/AST Enzymes Activities Change in Therapeutic and Toxic Doses Consumption of Acetaminophen in Rats
IBBJ Summer 2017, Vol 3, No 3 Original Article Hepatotoxicity and ALT/AST Enzymes Activities Change in Therapeutic and Toxic Doses Consumption of Acetaminophen in Rats Pouria jarsiah 1, Anahita Nosrati
More informationVIRAL HEPATITIS. Definitions. Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Acute Viral Hepatitis Symptoms
Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Definitions AST and ALT Markers of hepatocellular injury Ryan M. Ford, MD Assistant Professor of Medicine Director of Viral Hepatitis
More informationApixaban for stroke prevention in atrial fibrillation. August 2010
Apixaban for stroke prevention in atrial fibrillation August 2010 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to
More informationDrug Related Admissions to Intensive Care: The Role of Illicit Drugs and Self Poisoning
Original articles Drug Related Admissions to Intensive Care: The Role of Illicit Drugs and Self Poisoning M. A. CRETIKOS, M. J. A. PARR Intensive Care Unit, Liverpool Hospital, Liverpool, NEW SOUTH WALES
More informationHealthcare, hospitals and the challenges of an ageing population
Healthcare, hospitals and the challenges of an ageing population Prof David Oliver Vice President, RCP, London Past President, British Geriatrics Society Senior Visiting Fellow, King s Fund Consultant
More informationCoordination of palliative care in community settings. Summary report
Coordination of palliative care in community settings Summary report This resource may also be made available on request in the following formats: 0131 314 5300 nhs.healthscotland-alternativeformats@nhs.net
More informationAcetaminophen (APAP: N-acetyl-para-aminophenol)
Mathematical Modeling of Liver Injury and Dysfunction After Acetaminophen Overdose: Early Discrimination Between Survival and Death Christopher H. Remien, 1 Frederick R. Adler, 1,2 Lindsey Waddoups, 3
More informationManagement of the Frail Older Patients: What Are the Outcomes
Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT
More informationAcetaminophen (paracetamol) poisoning is the most. Acute Versus Chronic Alcohol Consumption in Acetaminophen-Induced Hepatotoxicity
Acute Versus Chronic Alcohol Consumption in Acetaminophen-Induced Hepatotoxicity Lars E. Schmidt, 1 Kim Dalhoff, 2 and Henrik Enghusen Poulsen 2 The aim of this study was to determine by multivariate analysis
More informationAcute Heart Failure. Study protocol
Acute Heart Failure Study protocol Study Advisory Group Lisa Anderson Cardiologist St Georges Joanne Bateman Lead pharmacist for cardiology Countess of Chester Paul Foley Cardiologist Swindon Jane Greaves
More informationChest Pain Wave I Webinar. May, 30 th 2017
Chest Pain Wave I Webinar May, 30 th 2017 Disclaimer The project described is supported by Funding Opportunity Number CMS-1L1-15-002 from the U.S. Department of Health & Human Services, Centers for Medicare
More informationRisk stratification in PBC
Risk stratification in PBC Christophe Corpechot Reference Center for Inflammatory Biliary Diseases Saint-Antoine hospital, Paris, France What is currently known (background) PBC : chronic, progressive
More informationSCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets
SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less S1 For pack sizes of more than 24 tablets PROPRIETARY NAME: AND DOSAGE FORM PANADO MELTABS (Tablets) COMPOSITION: Each tablet contains 500 mg
More informationContributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief.
Prescribing paracetamol in adult inpatients at MEHT Type: Clinical Guideline Register No: 18005 Status: Public on ratification Developed in response to: In line with Basildon Contributes to CQC Outcome
More informationAllied Health Professions in NHSScotland
Arts therapist Care assistant Dietitian Dietetic assistant Imaging support worker Limited orthotic practitioner Occupational therapist Occupational therapy assistant Orthoptist Physiotherapist Physiotherapy
More informationIn response to an enquiry from the Scottish Clinical Biochemistry Managed Diagnostic Network
Evidence Note Number 82 July 2018 In response to an enquiry from the Scottish Clinical Biochemistry Managed Diagnostic Network What is the most accurate and cost-effective direct test (ELF test, hyaluronic
More informationThe REACH project: Factors associated with intervals between women s visits to HIV outpatient clinics
The REACH project: Factors associated with intervals between women s visits to HIV outpatient clinics Dr Fiona Burns on behalf Dr Alison Evans and the REACH team Research Department of Infection and Population
More informationEndovascular or open repair for ruptured abdominal aortic aneurysm: 30-day outcomes from
Web supplement for Endovascular or open repair for ruptured abdominal aortic aneurysm: 30-day outcomes from the IMPROVE trial IMPROVE trial investigators Containing: page Risk differences for mortality
More informationThe Effects of Methionine on Paracetamol Induce Live Injury Hepatomegaly- (Animal Study)
The Effects of Methionine on Paracetamol Induce Live Injury Hepatomegaly- (Animal Study) Jawad F. H. Al- Musawi* Abstract This study which was done for a total (45) mice, over a time of 30 days, reflects
More informationNSAIDs Change Package 2017/2018
NSAIDs Change Package 2017/2018 Aim: To Reduce harm to patients from Non-Steroidal Anti-inflammatory Drugs (NSAIDs) in primary care Background A key aim of the Safety in Practice programme is to reduce
More informationA Guide to the Scottish Medicines Consortium
A Guide to the Scottish Medicines Consortium Providing advice about newly licensed medicines www.scottishmedicines.org About the Scottish Medicines Consortium The Scottish Medicines Consortium (SMC) provides
More informationCopyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and
Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere
More informationEMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY
EMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY Geriatrics, General practice, Emergency medicine, Interface medicine SUMMARY An integrated, community emergency service specifically designed for
More informationObservational Medical Outcomes Partnership
Implications of Health Outcomes of Interest Definitions: Acute Liver Injury Case Study Judy Racoosin, Patrick Ryan on behalf of OMOP Research Team Observational Medical Outcomes Partnership Established
More information